Old Web
English
Sign In
Acemap
>
authorDetail
>
Yidi Chen
Yidi Chen
Nanjing University of Chinese Medicine
Internal medicine
Transactivation
Endocrinology
glucose homeostasis
Nuclear receptor
4
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials.
2021
Medicine
Jingwen Zhou
Yidi Chen
Jun Yu
Tianci Li
Ziyu Lu
Yan Chen
Xiaolong Zhang
Fang Ye
Show All
Source
Cite
Save
Citations (1)
Antiallergic drug Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist.
2021
Metabolism-clinical and Experimental
Tong Zhao
Jie Wang
Yidi Chen
Shan Wang
Jian Lu
Jianlu Lv
Shiliang Li
Jiaying Wang
Minyi Qian
Honglin Li
Xu Shen
Show All
Source
Cite
Save
Citations (1)
FX5 as a non-steroidal GR antagonist improved glucose homeostasis in type 2 diabetic mice via GR/HNF4α/miR-122-5p pathway
2020
Xin Xu
Yidi Chen
Danyang Zhu
Tong Zhao
Rui Xu
Jiaying Wang
Lihong Hu
Xu Shen
Show All
Source
Cite
Save
Citations (2)
HS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter
2018
Metabolism-clinical and Experimental
Xin Xu
Xiaofan Shi
Yidi Chen
Tingting Zhou
Jiaying Wang
Xing Xu
Lili Chen
Lihong Hu
Xu Shen
Show All
Source
Cite
Save
Citations (10)
1